These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 10947858)

  • 1. New tuberculosis vaccines based on attenuated strains of the Mycobacterium tuberculosis complex.
    Collins DM
    Immunol Cell Biol; 2000 Aug; 78(4):342-8. PubMed ID: 10947858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
    Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of mutant mycobacteria as new vaccines to prevent tuberculosis.
    Hernàndez Pando R; Aguilar LD; Infante E; Cataldi A; Bigi F; Martin C; Gicquel B
    Tuberculosis (Edinb); 2006; 86(3-4):203-10. PubMed ID: 16542875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of avirulent mutants of Mycobacterium bovis with vaccine properties by the use of illegitimate recombination and screening of stationary-phase cultures.
    Collins DM; Wilson T; Campbell S; Buddle BM; Wards BJ; Hotter G; de Lisle GW
    Microbiology (Reading); 2002 Oct; 148(Pt 10):3019-3027. PubMed ID: 12368435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine and skin testing properties of two avirulent Mycobacterium bovis mutants with and without an additional esat-6 mutation.
    Collins DM; Kawakami RP; Wards BJ; Campbell S; de Lisle GW
    Tuberculosis (Edinb); 2003; 83(6):361-6. PubMed ID: 14623166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-Generation Vaccines Based on Bacille Calmette-Guérin.
    Nieuwenhuizen NE; Kaufmann SHE
    Front Immunol; 2018; 9():121. PubMed ID: 29459859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and protective efficacy of "Mycobacterium w" against Mycobacterium tuberculosis in mice immunized with live versus heat-killed M. w by the aerosol or parenteral route.
    Gupta A; Geetha N; Mani J; Upadhyay P; Katoch VM; Natrajan M; Gupta UD; Bhaskar S
    Infect Immun; 2009 Jan; 77(1):223-31. PubMed ID: 18981249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of attenuated Mycobacterium bovis strains by signature-tagged mutagenesis for discovery of novel vaccine candidates.
    Collins DM; Skou B; White S; Bassett S; Collins L; For R; Hurr K; Hotter G; de Lisle GW
    Infect Immun; 2005 Apr; 73(4):2379-86. PubMed ID: 15784584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant Mycobacterium bovis BCG.
    Bastos RG; Borsuk S; Seixas FK; Dellagostin OA
    Vaccine; 2009 Nov; 27(47):6495-503. PubMed ID: 19720367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCG vaccines: their mechanisms of attenuation and impact on safety and protective efficacy.
    Liu J; Tran V; Leung AS; Alexander DC; Zhu B
    Hum Vaccin; 2009 Feb; 5(2):70-8. PubMed ID: 19164935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in improved tuberculosis vaccines.
    McMurray DN
    Indian J Pediatr; 2000 Feb; 67(2 Suppl):S58-62. PubMed ID: 11129910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
    Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel vaccination strategies based on recombinant Mycobacterium bovis BCG.
    Dietrich G; Viret JF; Hess J
    Int J Med Microbiol; 2003 Feb; 292(7-8):441-51. PubMed ID: 12635927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving vaccines against tuberculosis.
    Britton WJ; Palendira U
    Immunol Cell Biol; 2003 Feb; 81(1):34-45. PubMed ID: 12534944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination of cattle against Mycobacterium bovis.
    Buddle BM
    Tuberculosis (Edinb); 2001; 81(1-2):125-32. PubMed ID: 11463233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection by novel vaccine candidates, Mycobacterium tuberculosis ΔmosR and ΔechA7, against challenge with a Mycobacterium tuberculosis Beijing strain.
    Marcus SA; Steinberg H; Talaat AM
    Vaccine; 2015 Oct; 33(42):5633-5639. PubMed ID: 26363381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel TB vaccine; towards a strategy based on our understanding of BCG failure.
    Agger EM; Andersen P
    Vaccine; 2002 Nov; 21(1-2):7-14. PubMed ID: 12443657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine.
    Jackson M; Phalen SW; Lagranderie M; Ensergueix D; Chavarot P; Marchal G; McMurray DN; Gicquel B; Guilhot C
    Infect Immun; 1999 Jun; 67(6):2867-73. PubMed ID: 10338493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in the development and testing of vaccines against human tuberculosis.
    McMurray DN
    Int J Parasitol; 2003 May; 33(5-6):547-54. PubMed ID: 12782054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.